New volume procurement: nearly half of the price limit is less than 1 yuan, and the minimum price is only 1 Mao. It is difficult to win the bid without reducing 50%!

Author: on the eve of new year's Day (December 29), a new round of belt purchasing document was issued, 33 varieties were officially selected, and January 17, 2020 (lunar month 23) was the bidding day This means that before the Spring Festival, there will be a large number of procurement bidding results After the dust is settled, no matter how happy or sad, everyone can have a good time This volume purchase is carried out nationwide, including public hospitals, military hospitals and private hospitals designated by medical insurance, with a larger scope In addition, the State Medical Insurance Bureau specially emphasizes to ensure the authenticity of the volume, so the market share is very attractive But the price reduction is more fierce when the quantity is large In the new round belt quantity purchase, the bidding rules have changed a lot, and the maximum price has been introduced The author finds that the minimum price of many varieties is too low, among which the maximum price of 22 varieties of the minimum quotation unit is less than 2 yuan, among which the maximum price of 16 varieties is less than 1 yuan, and the minimum price is only 0.1 yuan, i.e 1 yuan There are many changes in the bidding rules The game is used to block the situation that a bid can be won if there is less competition and less price reduction Under the new rules, even if there are fewer competitors, it is difficult for an enterprise to win without reducing price by 50% Are the bidding enterprises ready to reduce the price by 50% compared with the ceiling price? Metformin has survived According to the announcement of many provinces, the State Health Insurance Bureau requires public hospitals, military hospitals and private hospitals designated by medical insurance in all provinces to report the purchase volume of 35 varieties, while the official document has 33 varieties The sustained-release metformin dosage form and oral regular release metformin dosage form are not included in the official list of purchase volume According to the insight statistics of dingxiangyuan, metformin sustained-release dosage form and oral regular release dosage form are the most competitive varieties, and 11 manufacturers have passed the consistency evaluation respectively Up to 6 shortlisted companies have broken through the limit of up to 3 winning companies in the last round in terms of the number of winning manufacturers, which affects the procurement volume and the procurement cycle The more the actual application is, the more the number of shortlisted companies is The more the shortlisted companies are, the more the winning companies may be on the basis of meeting the bidding conditions Secondly, after the number of selected enterprises increases, the corresponding agreed purchase volume also increases to 80% at most, and the notice is clear: If there is one enterprise selected in practice nationwide, 50% of the calculation base of the agreed purchase volume in the first year; if there are two enterprises selected in practice nationwide, 60% of the calculation base of the agreed purchase volume in the first year; if there are three enterprises selected in practice nationwide, 70% of the calculation base of the agreed purchase volume in the first year; if there are four or more enterprises selected in practice nationwide, 80% of the calculation base of the agreed purchase volume in the first year Thirdly, the number of selected manufacturers also affects the procurement cycle In principle, the procurement cycle of the current round is one year for the actual selected enterprises in China; in principle, the procurement cycle of the current round is two years for the actual selected enterprises in China; in principle, the procurement cycle of the current round is two years for the actual selected enterprises in China; in principle, the procurement cycle of the current round is three years for the actual selected enterprises in China 22 When the maximum price of varieties is lower than 2 yuan, in the bid winning rules, a big change in the purchase of this round of belt quantity is that the maximum price of each variety is introduced, and the maximum price of many varieties is quite low According to the statistics of interesting academy, there are 22 varieties with the maximum price of the lowest quotation unit lower than 2 yuan in the 33 varieties purchased with volume, among which 16 varieties with the price lower than 1 yuan, which means that nearly half of the varieties have the price limit lower than 1 yuan, among which one specification is lower than 1 yuan, one specification is higher than 1 yuan, and the price of four varieties is between 1 and 2 yuan To become a shortlisted enterprise in the fierce competition, first of all, it needs to go through a round of price reduction According to the document, after the quotation, the shortlisted enterprises and supply areas are determined according to the order of price from low to high If the quotation is the same, the sales volume and market share are the influencing factors Because the current carrying volume is the national carrying volume, the sales volume and market share are actually a reflection of the supply capacity, reflecting the principle of supply guarantee When the document stipulates that the "unit comparable price" of the same variety declaration enterprise is the same, the specific determination rules are as follows: (1) in 2018, the enterprises with a large number of provincial supply areas will be given priority (based on the data submitted by each region); (2) in 2018, the enterprises with a large sales volume in each region will be given priority, the varieties with multiple specifications will be combined and calculated (based on the data submitted by each region); (3) Enterprises that have passed or deemed to have passed the consistency evaluation of quality and efficacy of generic drugs by the State Drug Administration shall have priority (subject to the approval date of the State Drug Administration); (4) enterprises that produce their own APIs shall have priority (referring to the same legal person as the manufacturers of APIs and preparations only) Bidding rules: no reduction of 50% will make it difficult to win the bid, but being shortlisted does not mean winning the bid In order to win the bid, one of the following three conditions must be met: 1 "Unit comparable price" is less than 1.8 times of the lowest "unit comparable price" of the same variety 2 The decrease of "unit application and quotation" shall be no less than 50.00% (based on the highest effective application and quotation of corresponding specifications in the catalogue of purchase varieties) The decrease is calculated as a percentage, rounded to 2 decimal places of the reserved percentage 3 "Unit comparable price" is less than or equal to 0.1000 yuan The price reduction logic of these three bid winning conditions is very interesting According to the current enterprises that have passed the consistency evaluation, there is not only one or two enterprises that are qualified for bidding In order to save space, the two situations will not be analyzed temporarily If there are three enterprises participating in the bidding, there are two shortlisted enterprises The enterprises will actively reduce the price to compete for the qualification, but the shortlisted enterprises are not equal to winning the bid In order to win the bid, the above three conditions must be met We take a variety as an example for analysis For example, three adefovir dipivoxil can participate in the offer, namely GlaxoSmithKline, Fujian guangshengtang and Qilu pharmaceutical, but only two of them are shortlisted after the offer After the two companies are shortlisted, if they want to win the bid, they must meet the following requirements: the bid price is less than 0.1 yuan / tablet, or the reduction of the offer price compared with the ceiling price (1.08 yuan / tablet) is 50% or more, that is, the offer price is less than 0.54 yuan / tablet In these two cases, winning the bid ensures that the winning enterprise either has super low price or reduces the price by more than 50% If the above two conditions are not met (i.e the reduction or the price is not up to standard), the principle of 1.8 times price difference must be met Similarly, if the price of adefovir dipivoxil is 0.32 yuan / tablet, Qilu will win the bid (because the decrease is more than 50%), and interesting things happen If the price of another shortlisted enterprise is higher than 0.54 yuan / tablet, because the decrease is lower than 50% and higher than 1 Mao / tablet, it does not meet the bid winning conditions, and it cannot be higher than 1.8 times (0.576 yuan / tablet) of Qilu if the price is higher than this price , and Qilu will win the bid exclusively It is said that both companies offer more than 0.54 yuan / tablet but less than the ceiling price (1.08 yuan / tablet) For example, one company offers 0.6 yuan / tablet and one company offers 0.9 yuan / tablet, both companies benefit If you think that's wrong again, there is another rule to ensure that a company will quote a low price According to the rules, if only one enterprise wins the bid, it can enjoy 50% of the agreed purchase quantity, and two enterprises can enjoy 60% of the agreed purchase quantity This means that the two winning bidders can only share 60% of the market, and each one can share about 30% of the market However, if an ultra-low quotation uses the 1.8x rule to squeeze out another competitor, it can enjoy 50% of the agreed purchase volume More than 20% of the national market share, this temptation is great In order to occupy more market, it is possible for one company to offer a super low price to squeeze out another shortlisted company Of course, as the exclusive bid winner only has one year's market, it will make enterprises think more about whether to bid at the ultra-low price But to be on the safe side, in order to ensure the bid winner, I believe that many enterprises will choose to reduce the price by at least 50% in order to avoid accidental bid winner due to the principle of 1.8 times The rule of 1.8 times is mainly aimed at the situation that there are few shortlisted enterprises, which blocks up the loophole that only one or two of the last round of belt quantity procurement have passed the consistency evaluation, and the price reduction is not much And the more enterprises participate in the bidding, the more fierce the enterprises will be in order to compete for the qualification, the more the price will be reduced, and the 50% reduction should be satisfied The maximum price limit of paracetamol is only 0.1 yuan / tablet, which basically meets the bid winning conditions However, because three companies have passed the consistency evaluation, only two can be shortlisted, and there will be price reduction competition, depending on how much the enterprise continues to reduce the price in order to win the bid In summary, for such ultra-low price varieties (1 Mao / tablet) and varieties with few competitors, there may be a decline of less than 50% But if the competition is fierce, it is not impossible to achieve or exceed 50% reduction For other non ultra-low price limited varieties, even if there are few shortlisted enterprises, it is difficult to win the bid if the price reduction rate is less than 50% Attachment: 37